Muckle-Wells syndrome


Also found in: Acronyms, Wikipedia.

Muck·le-Wells syn·drome

(muk'ĕl welz), [MIM*191900]
a syndrome characterized by amyloidosis, notably involving the kidneys, progressive sensorineural hearing loss, and periods of febrile urticaria associated with pain in joints and muscles of the extremities; autosomal dominant inheritance.

Muckle,

Thomas James, 20th century Canadian pediatrician.
Muckle-Wells syndrome - a syndrome characterized by familial amyloidosis.

Wells,

Michael Vernon, 20th century English physician.
Muckle-Wells syndrome - see under Muckle
References in periodicals archive ?
Three related conditions make up the broader disease known as CAPS: Familial Cold Auto-inflammatory Syndrome (FCAS), Muckle-Wells Syndrome (MWS), and Neonatal-Onset Multisystem Inflammatory Disease (NOMID).
In the United States, rilonacept (ARCALYSTA') is indicated for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) in adults and children 12 and older.
Ilaris is the first approved treatment for patients as young as four years old suffering from two forms of CAPS: familial cold auto-inflammatory syndrome (FCAS) and Muckle-Wells syndrome (MWS).
Nasdaq: REGN) today announced ARCALYST[TM] (rilonacept) Injection for Subcutaneous Use is now available for prescription in the United States for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) in adults and children 12 and older.
Food and Drug Administration (FDA) for ARCALYST[TM] (rilonacept) Injection for Subcutaneous Use, an interleukin-1 blocker, for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), including Familial Cold Auto-inflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS) in adults and children 12 and older.
Cryopyrin-Associated Periodic Syndromes (CAPS) is a spectrum of rare inherited inflammatory conditions, including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).
Currently, there are no medicines approved for patients suffering from CAPS, a spectrum of rare inherited inflammatory conditions, including Familial Cold Autoinflammatory Syndrome (FCAS) and Muckle-Wells Syndrome (MWS).